|
SEPSECS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.452090E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.637800E-02 |
| Normal-vs-Stage2 |
6.810200E-01 |
| Normal-vs-Stage3 |
4.984400E-03 |
| Normal-vs-Stage4 |
5.320800E-03 |
| Stage1-vs-Stage2 |
3.676800E-01 |
| Stage1-vs-Stage3 |
4.853800E-02 |
| Stage1-vs-Stage4 |
1.747610E-01 |
| Stage2-vs-Stage3 |
6.678000E-02 |
| Stage2-vs-Stage4 |
1.204200E-01 |
| Stage3-vs-Stage4 |
9.925800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.829500E-02 |
| Normal-vs-AfricanAmerican |
1.919790E-02 |
| Normal-vs-Asian |
4.369000E-04 |
| Caucasian-vs-AfricanAmerican |
3.556200E-01 |
| Caucasian-vs-Asian |
6.768100E-02 |
| AfricanAmerican-vs-Asian |
7.958400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.961700E-02 |
| Normal-vs-Female |
1.634500E-04 |
| Male-vs-Female |
3.544800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.341900E-03 |
| Normal-vs-Extreme_Weight |
1.063900E-02 |
| Normal-vs-Obese |
1.817750E-01 |
| Normal-vs-Extreme_Obese |
4.964200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.237800E-01 |
| Normal_Weight-vs-Obese |
1.787420E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.625600E-01 |
| Extreme_Weight-vs-Obese |
3.404800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.348000E-01 |
| Obese-vs-Extreme_Obese |
8.310000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.215900E-03 |
| Normal-vs-Age(41-60Yrs) |
3.955200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.778700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.281970E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.110300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.457800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.307000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.215500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.605970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.029000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.974800E-01 |
| Normal-VS-Type2 PRCC |
8.185500E-04 |
| Normal-VS-KIRP CIMP |
2.69340105774063E-11 |
| Normal-VS-Unclassified PRCC |
4.870600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.594100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
5.19030041168378E-10 |
| Type1 PRCC-VS-Unclassified PRCC |
7.219200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.92909999974233E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
8.816200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.78650000038606E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.616100E-02 |
| Normal-vs-N1 |
1.70516999999926E-05 |
| Normal-vs-N2 |
7.13390013729054E-10 |
| N0-vs-N1 |
3.053600E-02 |
| N0-vs-N2 |
4.01069999989012E-07 |
| N1-vs-N2 |
2.247800E-02 |
|
|
